Skip to content

PTSD: all studies

Page 184 of 211: studies 1,831 to 1,840 of 2,101, newest first. Back to the PTSD overview

Research

Sensitization to the prosocial effects of 3,4-methylenedioxymethamphetamine (MDMA).

Neuropharmacology June 2019 Daniel W Curry, Laís F. Berro, Andie R Belkoff et al.

The recreational drug 3,4-methylenedioxymethamphetamine (MDMA) has well documented prosocial effects and is currently under clinical investigation as a treatment for patients with PTSD, autism, and other conditions. Early clinical trials have found that MDMA-assisted therapy may have robust long-lasting therapeutic effects, yet the mechanism by which acute treatments produce these long-term...

DOI: 10.1016/j.neuropharm.2019.03.017 (opens in new tab) Full text (opens in new tab) MDMA 3,4-methylenedioxymethamphetamine 5-ht2a Sensitization +1

Randomized Controlled Trial of Imagery Rehearsal for Posttraumatic Nightmares in Combat Veterans.

Journal of Clinical Sleep Medicine May 15, 2019 Gerlinde C. Harb, Joan M. Cook, Andrea J Phelps et al.

Study objectives: To examine the efficacy of imagery rehearsal (IR) combined with cognitive behavioral therapy for insomnia (CBT-I) compared to CBT-I alone for treating recurrent nightmares in military veterans with posttraumatic stress disorder (PTSD). Methods: In this randomized controlled study, 108 male and female United States veterans of the Iraq and Afghanistan conflicts with current,...

DOI: 10.5664/jcsm.7770 (opens in new tab) Full text (opens in new tab) Humans Treatment outcome Dreams Stress disorders, post-traumatic +11

Portable Devices to Induce Lucid Dreams—Are They Reliable?

Frontiers in Neuroscience May 8, 2019 Sérgio Mota-Rolim, Achilleas Pavlou, George Nascimento et al. 25 citations

One of the main current challenges in lucid dreaming (LD) research is to develop a simple and reliable way to induce it (Stumbrys et al., 2012). This is because, for most people, LD is very pleasurable but also very rare (LaBerge and Rheingold, 1990; Mota-Rolim et al., 2013). Along with its recreational nature, LD also has potential clinical applications, such as the treatment of recurrent...

DOI: 10.3389/fnins.2019.00428 (opens in new tab) Lucid dream Sleep system call Circadian rhythm Cognitive psychology +1

EcoMeditation and Emotional Freedom Techniques (EFT) Produce Elevated Brain-wave Patterns and States of Consciousness

Energy Psychology May 1, 2019 Judith Pennington, Debbie Sabot, Dawson Church

Background Stress-reduction techniques can be used in combination with each other. Two such methods are Emotional Freedom Techniques (EFT) and EcoMeditation. EFT is an evidence-based self-help method. Reviews and meta-analyses examining more than 100 studies demonstrate the efficacy of EFT for anxiety, depression, and posttraumatic stress disorder (PTSD). EcoMeditation is a secular meditation...

Yoga and meditation: integrating mind-body medicine into a workplace wellness program. Police agency organizational and implementary considerations

International Journal of Complementary & Alternative Medicine April 16, 2019 Robelyn A. Garcia

When compared to society at large, police officers have particularly stressful lifestyles, placing them at greater risk of a multitude of stress related diseases in addition to overall mortality and decreased life expectancy.1,3–5 “Developing a comprehensive list of every stressor potentially confronted by policing officers would be an impossible task”.1 The number of years of service in police...

Conformational dynamics of the human serotonin transporter during substrate and drug binding.

Nature Communications April 11, 2019 Ingvar R Möller, Marika Slivacka, Anne Kathrine Nielsen et al. 92 citations

The serotonin transporter (SERT), a member of the neurotransmitter:sodium symporter family, is responsible for termination of serotonergic signaling by re-uptake of serotonin (5-HT) into the presynaptic neuron. Its key role in synaptic transmission makes it a major drug target, e.g. for the treatment of depression, anxiety and post-traumatic stress. Here, we apply hydrogen-deuterium exchange...

DOI: 10.1038/s41467-019-09675-z (opens in new tab) Full text (opens in new tab) Serotonin transporter Drug action Mass spectrometry

Early childhood adversity associations with nightmare severity and sleep spindles.

Sleep Medicine April 1, 2019 Tore Nielsen, Michelle Carr, Claudia Picard-Deland et al.

OBJECTIVE Childhood adversity figures prominently in the clinical histories of children and adolescents suffering from a panoply of physical, mental or sleep disorders, including posttraumatic stress disorder. But the nature and prevalence of early adversity in the case of idiopathic nightmare-prone individuals have received little study. We characterize the types and frequencies of...

MDMA and Pavlovian Fear Memory: Dose‐Effect Analysis

The FASEB Journal April 1, 2019 Madeline M. Pantoni, Stephan G Anagnostaras

±3,4‐methylenedioxymethamphetamine (MDMA) is a recreational drug that is also being pursued as a therapeutic for PTSD and other mood and anxiety disorders. Despite strong evidence of its therapeutic potential, these pursuits are hindered by evidence that MDMA produces robust neurotoxicity and cognitive deficits at high doses. These findings, however, may not generalize to typical recreational...

A Review of 3,4-methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy

Frontiers in Psychiatry March 20, 2019 Ben Sessa, David Nutt, Laurie Higbed 141 citations

This paper provides a brief review of the history, proposed pharmacological mechanisms, safety issues, and clinical applications of the medicine 3,4-methylenedioxymethamphetamine (MDMA). Most clinical MDMA research in patients to date has focused on MDMA-assisted psychotherapy to treat posttraumatic stress disorder (PTSD). In this review paper other potential therapeutic applications for MDMA...

The Past and Future of Psychedelic Science: An Introduction to This Issue

Journal of Psychoactive Drugs March 15, 2019 Lisa Jerome, Brad Burge, Richard Doblin et al. 87 citations

Psychedelic plants and fungi have been used in indigenous medicinal traditions for millennia. Modern psychedelic research began when Albert Hofmann first synthesized lysergic acid diethylamide (LSD-25) in 1938. Five years later, became the first person to ingest LSD. Hofmann was unaware of the significance of his actions, and the effects they would set in motion. After a burgeoning period of...